Autoradiography of 2‐[18F]F‐A‐85380 on nicotinic acetylcholine receptors in the porcine brain in vitro

Noninvasive molecular imaging of subtypes of neuronal nicotinic acetylcholine receptors (nAChRs) will provide information on the role of these receptors in neurodegenerative diseases. The binding of the positron emission tomography ligand 2‐[18F]F‐A‐85380 to nAChRs was investigated in the porcine brain by quantitative autoradiography in vitro. The high‐affinity binding of 2‐[18F]F‐A‐85380 to each of the investigated 12 brain areas was saturable and apparently monophasic (e.g., apparent KD value of 1.72 nM in the thalamus). The highest density of specific binding sites was observed in the thalamus (1,158 fmol/mg protein), and the lowest density was measured in the cerebellar gray matter (11 fmol/mg protein). An attempt to assess nAChR subtype specificity of 2‐[18F]F‐A‐85380 was made by competitive autoradiography. Binding of 2‐[18F]F‐A‐85380 coincubated with 2‐F‐A‐85380, epibatidine, cytisine, or methyllycaconitine, respectively, indicated a specificity of 2‐[18F]F‐A‐85380 to β2‐containing nAChRs in the porcine brain. The autoradiographic data confirmed the suitability of swine as a model for the evaluation of radioligands designed for imaging of nAChR subtypes in the living brain. Synapse 59:201–210, 2006. © 2005 Wiley‐Liss, Inc.

[1]  I. Jones,et al.  Why doesn't nicotinic ACh receptor immunoreactivity knock out? , 2005, Trends in Neurosciences.

[2]  Jean-Dominique Gallezot,et al.  In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  E. London,et al.  In vitro characterization of 6‐[18F]fluoro‐A‐85380, a high‐affinity ligand for α4β2* nicotinic acetylcholine receptors , 2005 .

[4]  D. Bertrand,et al.  Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain , 2004, Neuroscience.

[5]  P. Falkai,et al.  Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease. , 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[6]  C. Gotti,et al.  Neuronal nicotinic receptors: from structure to pathology , 2004, Progress in Neurobiology.

[7]  Jörg Steinbach,et al.  Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro. , 2004, Farmaco.

[8]  N. Volkow,et al.  6‐[18F]Fluoro‐A‐85380, a new PET tracer for the nicotinic acetylcholine receptor: Studies in the human brain and in vivo demonstration of specific binding in white matter , 2004, Synapse.

[9]  K. Kellar,et al.  Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells. , 2004, Bioorganic & medicinal chemistry letters.

[10]  Sheng-Kwei Song,et al.  Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition , 2004, Neurobiology of Disease.

[11]  L. Forno,et al.  Loss of α‐conotoxinMII‐ and A85380‐sensitive nicotinic receptors in Parkinson's disease striatum , 2004 .

[12]  D. Perry,et al.  Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor Autoradiography , 2003, Journal of Pharmacology and Experimental Therapeutics.

[13]  M. Bergström,et al.  Autoradiography with positron emitting isotopes in positron emission tomography tracer discovery. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[14]  Monique Ernst,et al.  2 [18F]F‐A85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  J. Changeux,et al.  Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]α‐bungarotoxin binding sites in the brain of Macaca mulatta , 2003, The Journal of comparative neurology.

[16]  Marcel Ricard,et al.  Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  E. Levin.  Nicotinic receptor subtypes and cognitive function. , 2002, Journal of neurobiology.

[18]  M. Quik,et al.  Declines in Different β2* Nicotinic Receptor Populations in Monkey Striatum after Nigrostriatal Damage , 2002, Journal of Pharmacology and Experimental Therapeutics.

[19]  M. Quik,et al.  Nicotine and nicotinic receptors; relevance to Parkinson's disease. , 2002, Neurotoxicology.

[20]  E. Perry,et al.  Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum , 2002, Neuroscience.

[21]  John L. Musachio,et al.  Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtypes in rat tissues by autoradiography , 2002 .

[22]  Simon R. Cherry,et al.  Effects of Image Resolution on Autoradiographic Measurements of Posterior Cingulate Activity in PDAPP Mice: Implications for Functional Brain Imaging Studies of Transgenic Mouse Models of Alzheimer's Disease , 2002, NeuroImage.

[23]  A. Buck,et al.  Synthesis and in vivo studies of the stereoisomers of N-[11C]methyl-homoepibatidine. , 2001, Nuclear medicine and biology.

[24]  J. Changeux,et al.  Localization of nAChR subunit mRNAs in the brain of Macaca mulatta , 2000, The European journal of neuroscience.

[25]  A. C. Collins,et al.  Identification of a novel nicotinic binding site in mouse brain using [125I]‐epibatidine , 2000, British journal of pharmacology.

[26]  J. Links,et al.  6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. , 2000, Life sciences.

[27]  J. Fowler,et al.  Synthesis and evaluation of 6-[(18)F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors. , 2000, Nuclear medicine and biology.

[28]  C. Gotti,et al.  Neuronal nicotinic receptors, important new players in brain function. , 2000, European journal of pharmacology.

[29]  A. Nordberg,et al.  Autoradiographic comparison of [3H](−)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease , 1999, Neuroscience.

[30]  C Crouzel,et al.  Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  H. Eisenberg,et al.  Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer’s disease: histotopographical correlation with amyloid plaques and hyperphosphorylated‐tau protein , 1999, The European journal of neuroscience.

[32]  C Crouzel,et al.  Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors. , 1999, Journal of medicinal chemistry.

[33]  E. London,et al.  Radiosynthesis and preliminary evaluation of 5-[123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine: a radioligand for nicotinic acetylcholine receptors. , 1999, Nuclear medicine and biology.

[34]  A. Buck,et al.  Synthesis and in Vivo studies of [C-11]N-methylepibatidine: comparison of the stereoisomers. , 1999, Nuclear medicine and biology.

[35]  M. Mesulam,et al.  Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. , 1998, Brain : a journal of neurology.

[36]  Agneta Nordberg,et al.  Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (±)-[3 H]epibatidine , 1998, Brain Research.

[37]  A. Nordberg,et al.  Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography , 1998, Neuroscience.

[38]  N. Volkow,et al.  In Vitro and Ex Vivo Autoradiographic Studies of Nicotinic Acetylcholine Receptors Using [18F]Fluoronorchloroepibatidine in Rodent and Human Brain , 1998 .

[39]  J. Changeux,et al.  Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice , 1998, The Journal of Neuroscience.

[40]  P. Plenge,et al.  Non-acetylcholine displaceable 3[H]epibatidine binding in the rat brain , 1998, Neuroscience Letters.

[41]  C. Crouzel,et al.  Synthesis of 2‐[18F]fluoro‐3‐[2(S)‐2‐azetidinylmethoxy]pyridine, a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors , 1998 .

[42]  A. C. Collins,et al.  Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. , 1998, Journal of Pharmacology and Experimental Therapeutics.

[43]  D. Donnelly-roberts,et al.  Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. , 1996, Journal of medicinal chemistry.

[44]  K. Kellar,et al.  [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. , 1995, The Journal of pharmacology and experimental therapeutics.

[45]  J. Lindstrom,et al.  Epitope mapping of polyclonal and monoclonal antibodies against two α-bungarotoxin-binding α subunits from neuronal nicotinic receptors , 1992, Journal of Neuroimmunology.

[46]  P. Whiting,et al.  Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  P. Clarke,et al.  Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  D Wyper,et al.  Nicotinic Acetylcholine Receptor Distribution in Alzheimer's Disease, Dementia with Lewy Bodies, Parkinson's Disease, and Vascular Dementia: In Vitro Binding Study Using 5-[125I]-A-85380 , 2004, Neuropsychopharmacology.